Prescription Free Drugs

Prescription Free Drugs Store
HomeAlpha IndexCategories

Drugs A

Drugs B

Drugs C

Drugs D

Drugs E

Drugs F

Drugs G

Drugs H

Drugs I

Drugs J

Drugs K

Drugs L

Drugs M

Drugs N

Drugs O

Drugs P

Drugs Q

Drugs R

Drugs S

Drugs T

Drugs U

Drugs V

Drugs W

Drugs X

Drugs Y

Drugs Z

Drugs 0-9

Home

Product Index

Category List

Lithicarb Eskalith

Home » Prescription Drugs 10 » Lithicarb Eskalith

Indications1.Treatment of mania and hypomania. 2.Lithium may also be tried in the treatment of some patients with recurrent bipolar depression for which treatment with other antidepressants has been unsuccessful. 3.Prophylactic treatment of recurrent affective disorders.Dosage and AdministrationA simple treatment schedule has been evolved which except for some minor variations should be followed whether using LITHICARB FC therapeutically or prophylactically. The minor variations to this schedule depend on the elements of the illness being treated and these are described later.1. In patients of average weight (70kg) an initial dose of 400- 1 200mg of LITHICARB FC may be given as a single daily dose in the morning or on retiring. Alternatively the dose may be divided and given morning and evening. The tablets should not be crushed chewed or swallowed with hot liquids. When changing from other lithium preparations serum lithium levels should first be checked then 2. LITHICARB FC therapy commenced at a daily dose as close as possible to the dose of the other form of lithium. As bioavailability varies from product to product (particularly with regard to retard or slow release preparations) a change of product should be regarded as initiation of new treatment. 3. Four to five days after starting treatment (and never longer than one week) a blood sample should be taken for the estimation of serum lithium level. 4. The objective is to adjust the LITHICARB FC dose so as to maintain the serum lithium level permanently within the diurnal range of 0.5 - 1.5 mmol/L. In practice the blood sample should be taken between 12 and 24 hours after the previous dose of LITHICARB FC. 'Target' serum lithium concentrations at 12 and 24 hours are shown in Table 1.LITHICARB FC tablets are scored therefore they can be divided accurately to provide dosage adjustments as small as 125mg. Serum lithium levels should be monitored weekly until stabilisation is achieved.Table 1. Target serum lithium concentrations "Target" serum lithium concentration (mmol/L) At 12 hours At 24 hours Once daily dosage 0.7 - 1.0 0.5 - 0.8 Twice daily dosage 0.5 - 0.8 4. Lithium therapy should not be initiated unless adequate facilities for routine monitoring of serum concentrations are available. Following stabilisation of serum lithium levels the period between subsequent estimations can be increased gradually but should not normally exceed three months. Additional measurements should be made following alteration of dosage on development of intercurrent disease signs of manic or depressive relapse following significant change in sodium or fluid intake or if signs of lithium toxicity occur. 5. Whilst a high proportion of acutely ill patients may respond within three to seven days of the commencement of LITHICARB FC therapy LITHICARB FC should be continued through any recurrence of the affective disturbance. This is important as the full prophylactic effect may not occur for 6 to 12 months after the initiation of therapy. 6. In patients who show a positive response to LITHICARB FC therapy treatment is likely to be long term. Careful clinical appraisal of the patient should be exercised throughout medication (see Precautions).Treatment of Acute Mania Hypomania and Recurrent Bipolar Depression:It is likely that a higher than normal LITHICARB FC intake may be necessary during an acute phase and divided doses would be required here. Therefore as soon as control of mania or depression is achieved the serum lithium level should be determined and it may be necessary dependent on the results to lower the dose of LITHICARB FC and re-stabilise serum lithium levels. In all other details the described treatment schedule is recommended.Prophylactic Treatment of Recurrent Affective DisordersIt is recommended that the described treatment schedule is followed.Use in the Elderly:In elderly patients or those below 50kg in weight it is recommended that the starting dose be 400mg. Elderly patients may be more sensitive to undesirable effects of lithium and may also require lower doses in order to maintain normal serum lithium levels. It follows therefore that long term patients often require a reduction in dosage over a period of years.Use in Children and AdolescentsNot recommended.

Buy Lithicarb Eskalith and other Prescription Drugs 10 products online at Medstore.

Buy Online at Medstore - Click Here!

About Lithicarb Eskalith:

Product Type: Prescription Drugs 10

Lithicarb ( Eskalith Generic Lithium Carbonate )

Lithicarb (Eskalith Generic Lithium Carbonate)

Eskalith Generic Lithium Carbonate

250mg Eskalith Generic Lithium Carbonate Lithicarb

View more Prescription Drugs 10

Previous Product  Next Product

Prescription Free Drugs: Information about cheap medication from Med Store - Very large generic medication selection; Everyday low medication prices; 20% free bonus pills for all refills and reorders; Strict medication quality standards; Free doctor consultations. MedStore guarantees delivery of your medication. If your order is not received, please let us know, and we will reship it FOR FREE. If for any reason, you feel that you are not completely satisfied with your order we will reship your order for free or will issue a full refund back to your credit card. Information on this site is provided for informational purposes and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing or treating a health problem or disease, or prescribing any medication. You should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your doctor. Thank you for visiting the MedStore Web site (the “Site”). MedStore is a leading online drugstore: a retail store and information site for health, beauty, wellness, personal care and pharmacy products. The Site is designed to provide a convenient, private and informative shopping experience for consumers to purchase products essential to healthy, everyday living. Accessible 24 hours a day, 7 days a week, the MedStore online store offers a larger selection of products than typical store-based retailers, along with a wealth of health-related information, buying guides and other tools designed to help consumers make educated purchasing decisions. EximStar WorldWide Ltd and its subsidiaries and affiliates (“we, us, our”) want each visitor to the Site (“you”) to have a safe, pleasurable visit, so we have established the following terms and conditions so that we (we and you) know what to expect from each other. By using the Site you agree to be bound by the terms set forth herein. We may make changes to the Site, these Terms of Use, or the policies and conditions that govern the use of the Site at any time. We encourage you to review the Site and these terms periodically for any updates or changes. Your continued access or use of the Site shall be deemed your acceptance of these changes and the reasonableness of these standards for notice of changes.
 
Medicine News : The first transgenic mouse model of a rare and severe type of autism called Timothy Syndrome is improving the scientific understanding of autism spectrum disorder in general and may help researchers design more targeted interventions and treatments. The research is described in a paper published last week by scientists at the University at Buffalo and Stanford University in the Proceedings of the National Academy of Sciences. The transgenic mouse developed at UB exhibits the repetitive physical behaviors, altered social behaviors and impaired communication abilities associated not just with Timothy Syndrome but with autism spectrum disorder in general. The fact that this mouse exhibited so many behavioral parallels with humans diagnosed with autism was both surprising and encouraging, the researchers say. "This animal and the syndrome that it is associated with, provides one of the best chances to understand the underlying mechanisms of autism," says Randall L. Rasmusson, PhD, professor of physiology and biophysics in the UB School of Medicine and Biomedical Sciences and co-author on the PNAS paper.
 
Femara (Letrozole) 
FEMILON Apri 
Femodene Generic Gestodene 
FENOLIP Antara 
FENOXENE Dibenzyline 
Fentoin ER Dilantin 
FERTOMID Clomid 
Fexigra Allegra 
FIBRAL Antara 
Finas Propecia 
Finasteride Generic Proscar 
FINCAR Proscar 
Finpecia (Finasteride) 
FINPECIA Propecia 
Finsava Propecia 
Flagyl Flagyl ER 
Flagyl (Metronidazol) 
Flarex FML 
Flatulence Preventer 
FleaDerm 
FLEXIDOL Generic Aceclofenac 
Flexital Trental SR 
FLEXURA GENERIC Metaxalone